BIND Therapeutics is a biotechnology company incorporated in 2006; Pfizer acquired substantially all of its assets in 2016. BIND’s product candidates were based on proprietary polymeric nanoparticles called ACCURINS®, which are engineered to target specific cells and tissues in the body at sites of disease. ACCURINS®, which continue to be developed with Pfizer, have the potential to achieve therapeutic outcomes not currently possible with conventional treatment modalities.
Looking for a particular BIND Therapeutics employee's phone or email?
BIND Therapeutics Questions
The BIND Therapeutics annual revenue was $15.4 million in 2026.
1 people are employed at BIND Therapeutics.
BIND Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for BIND Therapeutics are [325412, 325, 3254, 32, 32541].
The SIC codes for BIND Therapeutics are [283, 28].
Top BIND Therapeutics Employees
-
Gicela Vazquez
Receiving and operation associate at BIND Therapeutics
Massachusetts, United States32
Related Companies
